Literature DB >> 19105618

Cells and biomaterials in cartilage tissue engineering.

Martin J Stoddart1, Sibylle Grad, David Eglin, Mauro Alini.   

Abstract

Cartilage defects are notoriously difficult to repair and owing to the long-term prognosis of osteoarthritis, and a rapidly aging population, a need for new therapies is pressing. Cell-based therapies for cartilage regeneration were introduced into patients in the early 1990s. Since that time the technology has developed from a simple cell suspension to more complex 3D structures. Cells, both chondrocytes and stem cells, have been incorporated into scaffold material with the aim to better recreate the natural environment of the cell, while providing more structural support to withstand the large forces applied on the de novo tissue. This review aims to provide an overview of potential cell sources and different scaffold materials, which are in development for cartilage tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19105618     DOI: 10.2217/17460751.4.1.81

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  24 in total

1.  Magnetic resonance imaging probes for labeling of chondrocyte cells.

Authors:  Gang Liu; Chunchao Xia; Zhiyong Wang; Fei Lv; Fabao Gao; Qiyong Gong; Bin Song; Hua Ai; Zhongwei Gu
Journal:  J Mater Sci Mater Med       Date:  2011-01-30       Impact factor: 3.896

2.  Increased chondrocyte seeding density has no positive effect on cartilage repair in an MPEG-PLGA scaffold.

Authors:  Ole Møller Hansen; Casper Bindzus Foldager; Bjørn Borsøe Christensen; Hanne Everland; Martin Lind
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-04-10       Impact factor: 4.342

Review 3.  [Biomaterials in orthopedics].

Authors:  S Vogt; T Tischer; F Blanke
Journal:  Orthopade       Date:  2015-08       Impact factor: 1.087

4.  Characterization of a cartilage-like engineered biomass using a self-aggregating suspension culture model: molecular composition using FT-IRIS.

Authors:  Minwook Kim; Jeffrey J Kraft; Andrew C Volk; Joan Pugarelli; Nancy Pleshko; George R Dodge
Journal:  J Orthop Res       Date:  2011-05-31       Impact factor: 3.494

5.  The role of environmental factors in regulating the development of cartilaginous grafts engineered using osteoarthritic human infrapatellar fat pad-derived stem cells.

Authors:  Yurong Liu; Conor T Buckley; Richard Downey; Kevin J Mulhall; Daniel J Kelly
Journal:  Tissue Eng Part A       Date:  2012-05-31       Impact factor: 3.845

6.  Fabrication and characterization of interconnected porous biodegradable poly(ε-caprolactone) load bearing scaffolds.

Authors:  Rula M Allaf; Iris V Rivero
Journal:  J Mater Sci Mater Med       Date:  2011-06-14       Impact factor: 3.896

7.  Incorporation of biomimetic matrix molecules in PEG hydrogels enhances matrix deposition and reduces load-induced loss of chondrocyte-secreted matrix.

Authors:  Justine J Roberts; Garret D Nicodemus; Suzanne Giunta; Stephanie J Bryant
Journal:  J Biomed Mater Res A       Date:  2011-03-25       Impact factor: 4.396

8.  Bone marrow-derived mesenchymal stem cells versus bone marrow nucleated cells in the treatment of chondral defects.

Authors:  Yi Zhang; Fuyou Wang; Jiarong Chen; Zhigang Ning; Liu Yang
Journal:  Int Orthop       Date:  2011-10-28       Impact factor: 3.075

9.  Early induction of a prechondrogenic population allows efficient generation of stable chondrocytes from human induced pluripotent stem cells.

Authors:  Jieun Lee; Sarah E B Taylor; Piera Smeriglio; Janice Lai; William J Maloney; Fan Yang; Nidhi Bhutani
Journal:  FASEB J       Date:  2015-04-24       Impact factor: 5.191

10.  Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model.

Authors:  H Madry; G Kaul; D Zurakowski; G Vunjak-Novakovic; M Cucchiarini
Journal:  Eur Cell Mater       Date:  2013-04-16       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.